Miller RG, Secrest AM, Sharma RK, Songer TJ, Orchard TJ. Life expectancy in childhood-onset type 1 diabetes mellitus: the Pittsburgh Epidemiology of Diabetes Complications study cohort. Diabetes. 2012.
Secrest AM, Prince CT, Costacou T, Miller RG, Orchard TJ. Predictors of and survival after incident stroke in type 1 diabetes. Diab Vasc Dis Res. 2012.
McGuire ST, Secrest AM, Andrulonis R, Ferris LK. Surveillance of patients for early detection of melanoma: Patterns in dermatologist vs. patient discovery. Arch Dermatol. 2011;147(6):673-8.
Secrest AM, Costacou T, Gutelius B, Miller RG, Songer TJ, Orchard TJ. Associations between socioeconomic status and major complications in type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complication (EDC) Study. Ann Epidemiol. 2011;21(5):374-81.
Secrest AM, Costacou T, Gutelius B, Miller RG, Songer TJ, Orchard TJ. Association of socioeconomic status with mortality in type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study. Ann Epidemiol. 2011;21(5):367-73.
Secrest AM, Becker DJ, Kelsey SF, LaPorte RE, Orchard TJ. Characterizing sudden death and dead-in-bed syndrome in type 1 diabetes: Analysis from 2 childhood-onset type 1 diabetes registries. Diabet Med. 2011;28(3):293-300.
Secrest AM, Becker DJ, Kelsey SF, LaPorte RE, Orchard TJ. All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County Type 1 Diabetes Registry. Diabetes Care. 2010;33(12):2573-9.
Secrest AM, Becker DJ, Kelsey SF, LaPorte RE, Orchard TJ. Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County Type 1 Diabetes Registry. Diabetes. 2010;59(12): 3216-22.
Andrulonis R, Secrest AM, McGuire ST, Geskin LJ, Ferris LK. The influence of age and gender on reasons for seeking and expected benefits of skin cancer screening. Arch Dermatol. 2010;146(10):1097-1102.
Orchard TJ, Secrest AM, Miller RG, Costacou T. In the absence of renal disease, 20-year mortality risk in type 1 diabetes is comparable to that of the general population: A report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia. 2010;53(11):2312-9.